These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37997278)

  • 21. Review of safety and efficacy of approved systemic psoriasis therapies.
    Kaushik SB; Lebwohl MG
    Int J Dermatol; 2019 Jun; 58(6):649-658. PubMed ID: 30246393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classical to current approach for treatment of psoriasis: a review.
    Rahman M; Alam K; Ahmad MZ; Gupta G; Afzal M; Akhter S; Kazmi I; Jyoti ; Ahmad FJ; Anwar F
    Endocr Metab Immune Disord Drug Targets; 2012 Sep; 12(3):287-302. PubMed ID: 22463723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging systemic drugs in the treatment of plaque psoriasis.
    Balogh EA; Bashyam AM; Ghamrawi RI; Feldman SR
    Expert Opin Emerg Drugs; 2020 Jun; 25(2):89-100. PubMed ID: 32192366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Evolving Landscape of Psoriasis Treatment.
    Armstrong AW; Gordon KB; Menter MA; Wu JJ
    Semin Cutan Med Surg; 2018 Feb; 37(2S):S39-S43. PubMed ID: 29614136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current challenges and emerging drug delivery strategies for the treatment of psoriasis.
    Hoffman MB; Hill D; Feldman SR
    Expert Opin Drug Deliv; 2016 Oct; 13(10):1461-73. PubMed ID: 27164301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Psoriasis in the era of biologics].
    Torres T; Velho GC; Sanches M; Selores M
    Acta Med Port; 2010; 23(3):493-8. PubMed ID: 20654269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining Topical Psoriasis Treatment to Enhance Systemic and Phototherapy: A Review of the Literature.
    Bagel J; Gold LS
    J Drugs Dermatol; 2017 Dec; 16(12):1209-1222. PubMed ID: 29240856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New therapies under development for psoriasis treatment.
    García-Pérez ME; Stevanovic T; Poubelle PE
    Curr Opin Pediatr; 2013 Aug; 25(4):480-7. PubMed ID: 23838833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current and Future Therapies for Psoriasis with a Focus on Serotonergic Drugs.
    Martins AM; Ascenso A; Ribeiro HM; Marto J
    Mol Neurobiol; 2020 May; 57(5):2391-2419. PubMed ID: 32062841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety considerations with combination therapies for psoriasis.
    Nakamura M; Koo J
    Expert Opin Drug Saf; 2020 Apr; 19(4):489-498. PubMed ID: 31985309
    [No Abstract]   [Full Text] [Related]  

  • 31. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
    JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic review and estimated cost-efficacy of biologics compared with narrowband ultraviolet B light for the treatment of moderate to severe psoriasis and atopic dermatitis.
    McCoy T; Natarelli N; Pan A; Shakhbazova A; Sivamani RK; Chambers CJ
    Int J Dermatol; 2023 Aug; 62(8):986-999. PubMed ID: 37066447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small Molecules in the Treatment of Psoriasis.
    Torres T; Filipe P
    Drug Dev Res; 2015 Aug; 76(5):215-27. PubMed ID: 26255795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatments for psoriasis: A journey from classical to advanced therapies. How far have we reached?
    Hari G; Kishore A; Karkala SRP
    Eur J Pharmacol; 2022 Aug; 929():175147. PubMed ID: 35820531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of pediatric plaque psoriasis using biologics.
    Lansang P; Bergman JN; Fiorillo L; Joseph M; Lara-Corrales I; Marcoux D; McCuaig C; Pope E; Prajapati VH; Li SZJ; Landells I
    J Am Acad Dermatol; 2020 Jan; 82(1):213-221. PubMed ID: 31150699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis.
    Ghoreschi K; Balato A; Enerbäck C; Sabat R
    Lancet; 2021 Feb; 397(10275):754-766. PubMed ID: 33515492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New synthetic pharmacotherapeutic approaches to the treatment of moderate-to-severe plaque psoriasis in adults.
    Chandy RJ; Bridgeman SG; Godinich BM; Feldman SR
    Expert Opin Pharmacother; 2023 Jun; 24(8):959-967. PubMed ID: 37083505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psoriasis: Recent progress in molecular-targeted therapies.
    Honma M; Hayashi K
    J Dermatol; 2021 Jun; 48(6):761-777. PubMed ID: 33404109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.